Search / Trial NCT06221306

Crestal Bone Loss Around Narrow Diameter Implants Versus Standard Diameter Implants With Bone Augmentation in Horizontally Deficient Posterior Mandibular Sites.

Launched by CAIRO UNIVERSITY · Jan 13, 2024

Trial Information

Current as of December 21, 2024

Recruiting

Keywords

ClinConnect Summary

This clinical trial is investigating whether narrow diameter dental implants can effectively replace standard diameter implants in patients who have lost bone in the back of their lower jaw (mandible). Many patients face challenges when getting dental implants due to insufficient bone width, which often requires additional surgeries to build up the bone. This trial aims to see if using narrower implants can avoid these extra procedures, making the treatment simpler and less invasive.

To participate in the study, individuals should be at least 18 years old and have a specific amount of bone available in their jaw—at least 8 mm in height and 5-6 mm in width. Participants should also have had any teeth extracted at least three months prior and should be generally healthy, without conditions that could interfere with healing. Those who join the study can expect to receive either a standard or a narrow implant and will help researchers understand the best options for patients with limited bone. This research could lead to more straightforward treatments for many people needing dental implants.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients having mandibular edentulous posterior site requiring implant placement.
  • Available vertical bone height of ≥ 8 mm in the mandible and ridge width 5-6 mm in width.
  • Tooth extraction ≥3 months before surgical intervention.
  • Patients without systemic diseases interfering with implant therapy.
  • Patients aged ≥ 18 years old.
  • Good oral hygiene.
  • Exclusion Criteria:
  • Patients with systemic conditions known to affect bone metabolism and healing
  • Patients with habits that may jeopardize the implant longevity and affect the results of the study such as parafunctional habits.

Trial Officials

Manal Hosny, Professor

Study Director

Cairo University

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, , Egypt

Cairo, , Egypt

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0